Interestingly, curcumin treatment of GFI1-36N and -KD, NUP98-HOXD13-tg mice impeded AML progression significantly leading to a prolonged AML-free survival time (Figure 1B–D). Here, HOXD13 is linked to acute myeloid leukemia.